fbpx COVID-19 (Coronavirus): ADB's Response | Asian Development Bank

COVID-19 (Coronavirus): ADB's Response

ADB is supporting its developing members in responding to the COVID-19 pandemic through finance, knowledge, and partnerships.

In the Spotlight

News Release | 28 Oct 2021

$25 Million ADB Project to Help Procure COVID-19 Vaccines for Kyrgyz Republic

The Asian Development Bank has approved a $25 million project to help the Government of the Kyrgyz Republic procure and deploy COVID-19 vaccines and strengthen the country’s capacity to implement its vaccination program.

Op-Ed / Opinion | 16 Nov 2021

Raising Our Game to Overcome COVID - Ahmed M. Saeed and Suahasil Nazara

The sports journalist David Epstein’s best-selling book, “Range”, begins with the story of tennis great Roger Federer, who arrived at the pinnacle of his profession after a wandering journey through “basketball...

Article | 13 Sep 2021

ADB’s COVID-19 response for developing Asia surpasses $20 billion

ADB’s committed assistance to help its developing member countries address the COVID-19 pandemic including vaccination support has surpassed $20 billion

News Release | 11 DEC 2020

$9 Billion ADB Facility to Help Developing Member Countries Access and Distribute COVID-19 Vaccines

ADB has launched a $9 billion vaccine initiative—the Asia Pacific Vaccine Access Facility (APVAX)—offering rapid and equitable support to its developing member countries as they procure and deliver effective and safe COVID-19 vaccines.

ADB’s COVID-19 response consists of a $20 billion package announced in April 2020 and the $9 billion Asia Pacific Vaccine Access Facility (APVAX) announced in December 2020.

ADB’s initial $20 billion COVID-19 response package supports its developing member countries in countering the severe macroeconomic and health impacts caused by COVID-19, including $2.5 billion in concessional and grant resources, as well as $2 billion earmarked for the private sector (non-sovereign).

ADB's $9 billion APVAX vaccine initiative offers rapid and equitable support to its developing member countries as they procure and deliver effective and safe COVID-19 vaccines.

Committed Amount is the financing approved by ADB's Board of Directors or Management for which the legal agreement has been signed by the borrower, recipient, or the investee company and ADB.
*Projects may be listed in more than one country or subregion. The number of projects excludes short-term finance transactions under the Trade Finance, Supply Chain Finance, and Microfinance Programs.

News and Multimedia   Subscribe to our newsletter

Publications and Documents


Milestones

Made with Flourish